U.S., Aug. 22 -- ClinicalTrials.gov registry received information related to the study (NCT07778394) titled 'Personalized Addiction Treatment eHancement' on Aug. 18.
Brief Summary: Many patients stop medication-based treatments for Opioid Use Disorder (OUD) prematurely, placing them at increased risk for overdose and death. Providing targeted interventions for OUD, particularly through an accessible, digital health platform, is a potential way to enhance recovery and keep patients engaged in care. The current study seeks to test whether a digital mental health platform, delivered by peer recovery support specialists to individuals prescribed buprenorphine or methadone medication, will improve treatment outcomes for this high risk populatio...